Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

AbD Serotec

Jan 2009
AbD Serotec of Martinsried, Germany, and e2v biosensors of Chelmsford, UK, have launched a research program to perform feasibility studies showing proof of concept of the British company’s Visucare biosensor system. The system, a detection technology for biomarkers that uses a single-antibody immunoassay, will be used for protein quantification in point-of-care and near-patient testing.

AbD SerotecBiophotonicsdetection technologye2v biosensorsNews & FeaturesSensors & Detectors

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.